Gene Query: STAT5B

Dataset Description Geneva Score
ARS2 is a general suppressor of pervasive transcription [RNAseq] 58.13
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 42.88
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 32.76
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 30.82
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 30.82
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 30.53
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 29.36
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 29.03
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 29.03
Primary human trophoblast from term placenta 28.18
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 27.51
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 25.07
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 24.98
Identification of Nrf2 regulated genes by RNA sequencing 23.84
Nrf2 regulated genes in A549 cells 23.84
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 23.25
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 23.09
Nutritional control of protein translation 22.7
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 22.64
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 22.64
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 21.46
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 20.92
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 20.88
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 20.48
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 19.24
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 18.93
RNA-seq data from human lymphoma cell lines 18.72
ChIP-seq and RNA-seq from human lymphoma cell lines 18.72
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 18.72
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 18.71
The pause-initiation limit restricts transcription activation in human cells 18.36
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 17.55
Human neutrophil genome during PMA- and E. coli encounter-induced activation 17.55
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 17.48
Intrahepatic MAIT cell gene expression revealed by RNA-seq 17.17
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 16.93
PGE2 mediated gene expression changes in human cervical stromal cells 16.81
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 16.68
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 16.66
Regulation of highly expressed hCINAP on translatome 15.89
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 15.78
RNA-seq analyisis of PUM2 knockout cells 15.34
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 15.27
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 15.21
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 14.98
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 14.78
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 14.76
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 14.57
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 14.37
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 14.27
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 14.18
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 13.9
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 13.72
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 13.64
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 13.22
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 13.18
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 13.03
BCL11B 13.01
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 12.76
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 12.76
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 12.74
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 12.37
Neurofibroma 12.37
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 12.34
MEIS1 regulates hematopoiesis in hPSCs 12.0
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 11.99
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 11.93
mRNA expression profile of Lymphocytes by high-throuput sequencing 11.83
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 11.66
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 11.51
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 11.5
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 11.22
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 11.22
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 11.22
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 11.2
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 11.16
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 11.1
Zika infected neural stem cells 11.07
Transcriptome analysis of Zika infected neural stem cells 11.07
Comparing gene expression in iPSC derived RPE from control and AMD donors 11.02
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.99
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 10.94
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 10.94
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 10.82
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.7
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 10.64
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 10.58
Identification of long noncoding RNAs regulated by p53 10.56
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 10.55
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 10.48
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 10.41
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 10.39
Short and Long RNA sequencing of human mature erythrocytes 10.31
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 10.28
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 10.28
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 10.28
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 10.15
Transcriptome-wide identification of CELF2 functional targets in T cells 10.15
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 10.14
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 10.14
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 10.13
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.13
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 10.11
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 10.08
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 9.88
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 9.87
CHD1 regulates cell fate determination by activation of differentiation-induced genes 9.84
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.81
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 9.75
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 9.72
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.59
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.56
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.56
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.5
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.49
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 9.41
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 9.36
X-Ray induced DNA-Hydroxymethylation changes 9.33
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 9.33
Genetic-to-epigenetic Therapy for Pancreatic Cancer 9.27
Differentially expressed genes post knock down of lincDUSP26 9.07
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 9.04
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.04
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 9.02
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.95
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 8.92
TGF-β regulation of miRNA expression in pancreatic cancer 8.91
AMPK signaling for naïve pluripotency 8.86
AMPK signaling for naïve pluripotency [Hs] 8.86
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 8.85
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 8.79
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 8.79
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 8.77
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 8.75
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 8.72
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 8.69
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 8.66
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 8.65
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 8.63
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.61
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 8.59
Biological effect of chronic mistranslation in mammalian cells 8.57
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.56
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 8.54
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 8.53
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 8.41
Unique features and clinical importance of acute alloreactive immune responses 8.37
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 8.31
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 8.24
HNRNPM-regulated splicing dependencies in prostate cancer 8.24
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 8.23
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 8.23
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 8.23
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 8.21
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 8.18
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 8.16
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.09
Lysine benzoylation is a novel histone mark [RNA-seq] 8.05
Lysine benzoylation is a novel histone mark 8.05
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 8.02
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 8.01
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.98
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.91
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.89
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 7.86
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 7.86
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 7.86
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 7.81
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 7.78
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.74
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.73
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.73
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 7.72
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 7.64
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 7.64
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 7.63
Sensing self and nonself circular RNAs 7.61
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.59
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.59
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 7.58
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 7.56
DART-seq: an antibody-free method for global m6A detection 7.53
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 7.5
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.46
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.44
Trans-differentiation of human adult peripheral blood T cells into neurons 7.42
Landscape and variation of RNA secondary structure across the human transcriptome 7.38
Widespread intronic polyadenylation diversifies immune cell transcriptomes 7.34
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 7.33
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 7.32
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 7.32
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.17
N6-methyladenine DNA Modification in Glioblastoma 7.17
Gene expression changes associated with resistance to tagraxofusp (SL-401) 7.17
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 7.12
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 7.1
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 7.02
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 7.02
Widespread regulated alternative splicing of single codons accelerates proteome evolution 6.96
Transcriptome sequencing of K-562 cells 6.95
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 6.95
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.94
RNA-seq of tumor cells following angiopellosis extravasation 6.94
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 6.94
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 6.93
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 6.9
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 6.89
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.88
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.84
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 6.81
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.81
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.74
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 6.74
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 6.74
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.69
6.68
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.67
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.67
A novel target of EZH1/2 for treatment of mantle cell lymphoma 6.66
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 6.63
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 6.58
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.57
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.57
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 6.53
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 6.53
Transcriptomic analysis of the HOTAIR-regulated genes 6.51
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 6.51
Accurate annotation of human protein-coding small open reading frames 6.51
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 6.5
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 6.49
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 6.48
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 6.42
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 6.42
Intron retention induced by microsatellite expansions as a disease biomarker. 6.41
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 6.4
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 6.4
Co-regulation of splicing by Rbfox1 and hnRNP M 6.4
Transcriptome analysis upon C6orf203 silencing 6.39
miR941 overexpression experiment 6.37
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.31
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 6.31
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 6.27
RNA-seq of YB5 cells treated with Proscillaridin A 6.26
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 6.22
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 6.2
Trascriptome of thyroid cancer-induced macrophages 6.17
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 6.14
Loss of CREBBP results in gene expression repression in lymphoma cells 6.14
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 6.13
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 6.13
miRNAs affected by antagomiR-17 treatment 6.06
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 6.06
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 6.06
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 6.05
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 6.05
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 6.05
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 6.03
LIN28A modulates splicing and gene expression programs in breast cancer cells 6.03
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.03
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 6.02
snRNAs as regulators of alternative splicing 6.0
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 5.89
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 5.86
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 5.85
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.8
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 5.79
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.78
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 5.77
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 5.75
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.74
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.69
BI Human Reference Epigenome Mapping Project 5.68
Transcriptomes of human monocytes after ex vivo exposure to uric acid 5.64
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.64
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 5.62
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 5.61
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 5.61
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 5.61
Lineage specific differentiation is influenced by state of human pluripotency 5.61
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 5.57
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.54
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 5.52
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 5.49
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 5.48
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 5.48
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 5.43
RNA sequencing of primary human platelets and in vitro cell lines 5.42
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.36
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 5.32
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 5.24
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 5.24
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.18
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.18
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 5.15
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 5.15
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 5.07
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.02
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.02
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.02
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.96
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 4.92
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.8
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.79
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 4.78
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.72
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 4.7
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.65
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.64
Single-Cell Genotyping of Transcriptomes 4.64
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 4.63
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 4.63
RNA expression analysis upon JMJD1C depletion 4.6
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 4.6
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 4.57
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 4.57
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.55
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.5
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 4.5
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 4.47
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 4.42
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.29
TAF1 is critical for AE driven leukemogenesis 4.29
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.27
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.23
Transcriptome analysis of CNS leukemia 4.23
Transcriptomic analysis of LSD1 4.14
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.1
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.08
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 4.04
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 4.02
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.94
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.88
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.84
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.8
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.77
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.76
Gene expression profile in breast cancer cells 3.76
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.75
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.75
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.73
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.72
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.7
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 3.69
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.67
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 3.53
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.51
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 3.49
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.44
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.4
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.36
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.33
In vitro modeling of human germ cell development using pluripotent stem cells 3.31
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.27
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 3.27
Induced DNA demethylation, genome instability and transcription 3.27
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.26
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.18
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.14
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 3.09
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.04
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 3.02
Oncogenic roles of ARID5B in T-ALL 3.02
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.0
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.0
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.96
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 2.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.94
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.92
Transcriptome analysis of peripheral blood monocytes 2.9
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.85
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.76
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.73
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.59
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.58
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.56
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.5
SOX11 knockdown in B-ALL cell lines 2.49
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 2.45
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 2.45
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 2.45
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.44
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 2.43
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 2.3
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.28
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 2.28
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 2.28
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.26
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.25
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.21
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.2
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 2.13
Differences in miRNA Detection Levels are Technology and Sequence Dependent 2.13
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.13
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.12
miR-93 Targets in Human Endothelial Cells 2.12
RNAseq of Breast cancer PDX samples 2.11
Clinker: visualizing fusion genes detected in RNA-seq data 2.1
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 2.06
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 2.06
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.06
Expression profiles of the four human major ectodermal lineages 2.04
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.97
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.92
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.92
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 1.89
Human Treg IFNg/IL-10 subpopulations 1.89
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.88
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.88
Function and hormonal regulation of GATA3 in human first trimester placentation 1.85
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 1.85
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 1.81
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 1.8
RNA-Seq in PWS iPSC-derived neurons 1.79
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.72
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.71
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.71
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 1.7
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 1.7
Transcriptome-wide modulation of splicing by the exon junction complex 1.66
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.63
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 1.6
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.54
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 1.48
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.44
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 1.36
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.23
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.19
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.19
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.17
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.17
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.16
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.16
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.16
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.11
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.11
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.09
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.04
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.0
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.0
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 0.99
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.98
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 0.96
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 0.96
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 0.96
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.94
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.94
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.94
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.93
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 0.88
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.85
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.84
Transcriptome-wide response to synthetic chromatin protein PcTF 0.84
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.83
Enhancer activation during EGF response 0.77
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.76
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.76
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.75
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.73
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.72
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.72
The role of m6A/m-RNA methylation in stress response regulation 0.7
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.7
Modeling Human Cancer-induced Cachexia (Human) 0.64
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.62
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.6
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.6
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.6
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.56
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.56
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.55
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.55
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.54
Characterization of parental and rociletinib-resistant derived H1975 cell lines 0.52
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.51
Gene expression changes due to PARP knockdown in human cells 0.48
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.45
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.45
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.43
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.42
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.42
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.39
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.39
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.31
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.3
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.28
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 0.28
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.25
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.25
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.25
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.19
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.14
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.14
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.11
RNA-seq of primary patient AML samples 0.09
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.08
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.04
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.02
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation